The ideal candidate will be: Individuals with a body mass index (BMI) of 30 or higher, or Individuals with a BMI of 27 or higher with at least one weight-related condition (e.g., Type 2 diabetes, high blood pressure, or high cholesterol)
however, in most trials, there was no significant difference between men and women in reaching these thresholds
What makes it a better choice: Comprehensive coverage for foundational daily nutrient support Women-focused formulation instead of a generic multivitamin approach Twice-daily dosing , which can support better absorption and gentler tolerance for some women Bioavailable nutrients , which matter when digestion and intake are already compromised Support for energy, metabolism, hair, skin, immune health, and overall resilience For women on GLP-1, that combination matters
This novel approach to the development of MEDI7219 provides a template for the development of other oral peptide therapeutics